Sign In

henry copeland:

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

Drug–placebo differences in antidepressant efficacy increase as a function of baseline severity, but are relatively small even for severely depressed patients. The relationship between initial severity and antidepressant efficacy is attributable to decreased responsiveness to placebo among very severely depressed patients, rather than to increased responsiveness to medication.
- journals.plos.org
medicalindustrialcomplex depression serotonin SSRI
FAQ | Blog | DMCA
© 2025 Pressflex LLC